Allopurinol Outcome Study

NCT01391325 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1735

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Allopurinol

Sponsor

Ardea Biosciences, Inc.